| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855509 Measurement of protein s activity in sample; obtain sample, monitor clotting time, compare to control, evaluate protein s activity |
| 02/15/2005 | US6855497 Detecting spinocerebellar ataxia; obtain tissue sample, incubate with probe, hybridization of probe indicates spinocerebellar ataxia |
| 02/15/2005 | US6855496 Detection of preferential nucleic acid ligands; obtain nucleotide sequences, incubate with oligonucleotides, hybridize, amplify, recover nucleotide sequences |
| 02/15/2005 | US6855494 Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures |
| 02/15/2005 | US6855323 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
| 02/15/2005 | US6855322 A highly purified protein, Plasmodium falciparum MSP-142, which retains folding and disulfide bridging of the native molecule and is useful as a diagnostic reagent, antibody production, and as a vaccine for malaria |
| 02/15/2005 | US6855321 Polyepitope carrier protein |
| 02/15/2005 | US6855320 Fusing to the antigen a non-hemolytic truncated form of listeriolysin O. |
| 02/15/2005 | US6855319 Gene encoding merozoite protein of Babesia caballi, recombinant protein obtained therefrom and utilization thereof |
| 02/15/2005 | US6855318 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes |
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/15/2005 | US6855316 Combination of an adjuvant and an isolated p42 polypeptide comprising at least a portion of the 42 kDa C-terminal processing fragment of major merozoite surface protein gp195 from a Plasmodium falciparum isolate |
| 02/15/2005 | US6855308 Anticancer, antitumor agents |
| 02/15/2005 | US6854731 Method and device for playing an improved game of blackjack |
| 02/10/2005 | WO2005012910A1 A peptide antigen |
| 02/10/2005 | WO2005012904A1 Compositions and methods for monitoring breast cancer treatment |
| 02/10/2005 | WO2005012902A1 Method of screening useful protein |
| 02/10/2005 | WO2005012606A2 Concentrated aqueous silk fibroin solution and use thereof |
| 02/10/2005 | WO2005012545A2 Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors |
| 02/10/2005 | WO2005012538A2 Accelerated vaccination |
| 02/10/2005 | WO2005012536A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 02/10/2005 | WO2005012535A2 Method for producing life attenuated viruses and use of viral particles thus produced. |
| 02/10/2005 | WO2005012532A1 System for the production of dimeric proteins based on the transport system of hemolysin of escherichia coli |
| 02/10/2005 | WO2005012531A2 Antibody cdr polypeptide sequences with restricted diversity |
| 02/10/2005 | WO2005012530A2 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | WO2005012527A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 02/10/2005 | WO2005012526A1 Lafora's disease gene |
| 02/10/2005 | WO2005012520A1 Gene imparting redifferentiation ability of plant and utilization of the same |
| 02/10/2005 | WO2005012517A2 Use of the fret phenomenon for in vivo follow-up of biological events |
| 02/10/2005 | WO2005012516A2 Maize cellulose synthases and uses thereof |
| 02/10/2005 | WO2005012512A1 Scaffold-free self-organized 3d synthetic tissue |
| 02/10/2005 | WO2005012498A2 Production of porphyrins |
| 02/10/2005 | WO2005012492A2 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | WO2005012491A2 Surface expression of biologically active proteins in bacteria |
| 02/10/2005 | WO2005012489A2 Targeting endothelium for tissue-specific delivery of agents |
| 02/10/2005 | WO2005012481A2 Non-immunoglobulin binding polypeptides |
| 02/10/2005 | WO2005012363A1 Targeting inflammation inducer |
| 02/10/2005 | WO2005012360A2 Binding molecules against sars-coronavirus and uses thereof |
| 02/10/2005 | WO2005012359A2 Anti-vegf antibodies |
| 02/10/2005 | WO2005012357A1 Bcl-2 splicing variants |
| 02/10/2005 | WO2005012356A2 Gelatin capsules |
| 02/10/2005 | WO2005012355A1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 02/10/2005 | WO2005012353A1 Crystalline tumor necrosis factor receptor 2 polypeptides |
| 02/10/2005 | WO2005012352A1 SOLUBLE HUMAN INTERLEUKIN 18 RECEPTOR-α, METHOD OF ASSAYING THE SAME, ASSAY KIT AND MEDICINAL COMPOSITION |
| 02/10/2005 | WO2005012351A2 Novel functions for decay accelerating factor (daf) in inflammation |
| 02/10/2005 | WO2005012350A2 Epha2 t-cell epitope agonists and uses therefor |
| 02/10/2005 | WO2005012349A2 Chromatographic process for the purification of notch ligands |
| 02/10/2005 | WO2005012348A2 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 02/10/2005 | WO2005012346A1 Long lasting insulin derivatives and methods thereof |
| 02/10/2005 | WO2005012345A1 Perfusion method for producing erythropoietin |
| 02/10/2005 | WO2005012344A1 Adipocyte complement related protein zacrp11 |
| 02/10/2005 | WO2005012343A1 Babesia vaccines |
| 02/10/2005 | WO2005012342A1 Process for preparation of flax protein isolate |
| 02/10/2005 | WO2005012341A2 Pichia methanolica secretory signal |
| 02/10/2005 | WO2005012340A1 Nematicidal proteins |
| 02/10/2005 | WO2005012339A2 Immunogenic protein and uses thereof |
| 02/10/2005 | WO2005012338A1 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2005012337A2 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2005012336A2 Uranium-chelating peptides and uses thereof |
| 02/10/2005 | WO2005012330A2 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 02/10/2005 | WO2005011742A1 Method of treating hepatocellular carcinoma |
| 02/10/2005 | WO2005011733A1 Hybrid toxins comprising shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 02/10/2005 | WO2005011732A2 Rabbit bacterium and uses thereof |
| 02/10/2005 | WO2005011724A1 A method of producing an anticoagulation effect |
| 02/10/2005 | WO2005011722A2 Use of vegf-c or vegf-d in reconstructive surgery |
| 02/10/2005 | WO2005011607A2 Treatment of cancers expressing p95 erbb2 |
| 02/10/2005 | WO2005011584A2 Decorin proteoglycan inhibitor of fibrinogen blood clotting |
| 02/10/2005 | WO2005011571A2 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 02/10/2005 | WO2005011367A1 A chloroplast transgenic approach to express and purify human serum albumin, a protein highly susceptible to proteolytic degradation |
| 02/10/2005 | WO2004111249A3 Protein constructs containing caspase recognition sites |
| 02/10/2005 | WO2004111088A3 Angiogenic factor and inhibitors thereof |
| 02/10/2005 | WO2004111081A3 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2004107618A3 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 02/10/2005 | WO2004097421A3 Diagnostics and therapeutics for diseases associated with calcitonin receptor-like receptor (calcrl) |
| 02/10/2005 | WO2004094462A3 Methods of peptide preparation |
| 02/10/2005 | WO2004093903A3 Methods and compositions for immunomodulation using cd1 antigens |
| 02/10/2005 | WO2004092397A3 Tmprss2 regulatory sequences and uses thereof |
| 02/10/2005 | WO2004087755A3 Plant haemoglobin |
| 02/10/2005 | WO2004083807A3 Methods of evaluating glycomolecules for enhanced activities |
| 02/10/2005 | WO2004078112A3 Apoptosis inducing gene |
| 02/10/2005 | WO2004069865A3 Control of plant growth and developmental processes |
| 02/10/2005 | WO2004058188A3 Vaccine compositions and methods |
| 02/10/2005 | WO2004057941A3 RECESSIVE PLANT VIRAL RESISTANCE RESULTS FROM MUTATIONS IN TRANSLATION INITIATION FACTOR eIF4E |
| 02/10/2005 | WO2004056960A3 Gene-coding polynucleotides of the chromosome of the bacterium chromobacterium violaceum, expression and activity of these polynucleotides and their applications |
| 02/10/2005 | WO2004054907A3 Ftsz-polypeptides as a target for herbicidal compounds |
| 02/10/2005 | WO2004043332A3 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 02/10/2005 | WO2004035774A3 Expression vectors for selection from stem cells of differentiated cardiomyocytes |
| 02/10/2005 | WO2004024863A3 Adenoviral va1 pol iii expression system for rna expression |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2004020589A3 The gene for a dof transcription factor capable of altering the size and stature of a plant |
| 02/10/2005 | WO2004016647A3 Fragments of proinsulin c-peptide |
| 02/10/2005 | WO2004003207A9 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003083079A9 Bone generation by gene therapy |
| 02/10/2005 | WO2003072731A3 STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS |
| 02/10/2005 | WO2003072723A3 Intracellular signaling molecules |
| 02/10/2005 | WO2003068943A3 Secreted proteins |
| 02/10/2005 | WO2003063760A3 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 02/10/2005 | WO2003060065A3 Adapter-directed display system |